GGrantIndex
← Leaderboards

Loyola University Chicago

Maywood, IL

Compare ↔
$503,248,921
Total funding
538
Grants

Funding over time

peak $27.6M · FY2005–25
$50M$37.5M$25M$12.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$503,248,921 · 538

By mechanism

R01$358,373,183 · 239
R21$24,767,015 · 70
P01$23,428,877 · 31
U01$15,110,691 · 6
T32$11,551,870 · 4
R35$10,477,470 · 6

Investigators at Loyola University Chicago

Investigator-initiatedAll funding

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

1Irida Kastrati$2,252,2221 gr2Grace Kim Muller$1,294,2791 gr3Sean William Fanning$1,030,5191 gr4Monsheel S Sodhi$711,3611 gr5Thao T Griffith$519,0541 gr6John Kubasiak$423,5001 gr7Olga Kalinina$423,5001 gr8Dorothy K. Sojka$223,0681 gr

Emerging Leaders

6–10 yrs in

1Harel Dahari$6,227,5004 gr2Jonathan A Kirk$5,531,4294 gr3Lara Ruth Dugas$4,800,5252 gr4Andrew T Ulijasz$3,928,0012 gr5Jordan Beach$2,378,7601 gr6Jonathan Ozik$2,212,4583 gr7Virginie Mansuy Aubert$1,855,3451 gr8John Roeske$1,086,0911 gr

All-Time

Most funded here, all years

1Elizabeth J Kovacs$19,849,11717 gr2Katherine L Knight$17,196,73814 gr3Dmitry Isaac Gabrilovich$14,466,78911 gr4Seth L Robia$13,621,9904 gr5Michael Fill$12,914,0177 gr6Richard Stanley Cooper$12,608,2485 gr7Hua Huang$11,600,8508 gr8Edward M Campbell$10,934,12012 gr

Largest grants

TCR Gene Modified T Cells for Adoptive Immunotherapy$3,493,020
P01 · FY2012 · CA
TCR Gene Modified T Cells for Adoptive Immunotherapy$3,406,082
P01 · FY2015 · CA
TCR Gene Modified T Cells for Adoptive Immunotherapy$3,295,681
P01 · FY2014 · CA
TCR Gene Modified T Cells for Adoptive Immunotherapy$3,141,645
P01 · FY2013 · CA
Loyola Research Computing Core$2,701,560
G20 · FY2010 · RR
CaMKII and IP3-Mediated Signaling in Cardiac Myocytes$2,260,444
P01 · FY2006 · HL
CaMKII and IP3-Mediated Signaling in Cardiac Myocytes$2,248,646
P01 · FY2008 · HL
CaMKII and IP3-Mediated Signaling in Cardiac Myocytes$2,237,427
P01 · FY2007 · HL
Weighting Longitudinal Data to Access Opioid Analgesia Tapering Outcomes among Patients with Co-occurring Chronic Pain and Substance Use Disorder$2,093,521
R01 · FY2022 · DA
TCR Gene Modified T Cells for Adoptive Immunotherapy$2,032,647
P01 · FY2011 · CA
SELENOF is a Novel Tumor Suppressor and a New Target to Overcome Health Disparity in Breast Cancer$1,356,803
R01 · FY2025 · CA
Collaborative Integration of HCV Molecular Virology and Mathematical Modeling$1,265,369
R01 · FY2025 · AI
Molecular genetics of MLL-associated leukemia$1,210,621
P01 · FY2009 · CA
Molecular genetics of MLL-associated leukemia$1,187,822
P01 · FY2005 · CA
Molecular genetics of MLL-associated leukemia$1,178,313
P01 · FY2008 · CA
Molecular genetics of MLL-associated leukemia$1,171,454
P01 · FY2006 · CA
Molecular genetics of MLL-associated leukemia$1,166,954
P01 · FY2007 · CA
CELL THERAPY CORE$1,080,576
P01 · FY2015 · CA
Cell Therapy Core$1,041,313
P01 · FY2012 · CA
ADVANCED POP AND THE URINARY CONTINENCE MECHANISM$1,024,005
U10 · FY2004 · HD